mynth
← DATABASE
04/2017

VENTION ADVANCED TECHNOLOGIES acquired by NORDSON CORPORATION

UNITED KINGDOM Life Sciences / Medical Devices EV $500M–1.5bn

Context

The acquisition of Vention Advanced Technologies by Nordson Corporation signifies a major step in the group’s expansion into the high-growth medtech sector. The strategic logic of this transaction hinges on a "market-balancing" maneuver, merging the target’s industry-leading technical operational depth in interventional delivery systems with the buyer’s established scale in precision fluid management. This alignment equips the combined organization with the scientific talent and manufacturing hardware necessary to address the increasing demand for minimally invasive medical solutions across North America, Europe, and Asia. This maneuver allows the organization to execute a definitive structural expansion of its technical suite, particularly in the single-use fluid management and biomaterial delivery segments.

VENTION ADVANCED TECHNOLOGIES, which reported an EBITDA margin of [members only] in 2017, is valued in this transaction at an EV/EBITDA multiple of 10x–18x, representing a premium to the average currently observed in the Healthcare & Pharma sector (14.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Vention Advanced Technologies is a Medical Components & Interventional Devices company based in Salem, New Hampshire, specializing in the technical development of minimally invasive delivery systems. The entity provides critical engineering solutions for the global medical technology industry, primarily focusing on the mechanical integrity of catheters, specialty medical tubing, and balloons. Rather than offering generic healthcare products, the firm operates a sophisticated manufacturing infrastructure dedicated to extrusion, nitinol forming, and complex component assembly. Its utility resides in its ability to support medical device manufacturers from initial design through full-scale industrial production.

Ent. Value

$500M–1.5bn

Equity Value

[members only]

Multiples

EV / Revenue

2x–6x

EV / EBITDA

10x–18x

EV / EBIT

[members only]

Historical Financials (USD)

Year
Rev
EBITDA
EBIT
2017
$100–200M
$25–50M
[members only]
2016
$100–200M
$25–50M
[members only]

Similar deals in Life Sciences

Similar deals in Life Sciences

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
DateAcquirerTargetCountrySector
06/2017CHARTERHOUSESERBBELGIUMPharma & Biotech
05/2017PAI PARTNERSELITECH GROUPFRANCEDiagnostic Equipment
04/2017BAIN CAPITAL / CINVENSTADAGERMANYGenerics / Labs
03/2017ARDIANUNITHERFRANCECDMO
02/2017ECOLABLABORATOIRES ANIOSFRANCEMedical Consumables
09/2016ARCHIMEDPOLYPLUSFRANCER&D Biotech
09/2016ARDIAN / IXO PRIVATE EQUITYLAGARRIGUEFRANCEImplants & Prosthetics
06/2016BRIDGEPOINT / RAISE / FLEXSTONE PARTNERSACTEONFRANCEMedical Devices
06/2016PAI PARTNERSATOS MEDICALSWEDENMedical Consumables
06/2016PAI PARTNERSETHYPHARMFRANCEPharma & Biotech

REFERENCES

Valuation range: EV $500M–1.5bn

Revenue range: $100–200M

EBITDA range: $25–50M

EV/Revenue range: 2x - 6x

EV/EBITDA range: 10x - 18x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of VENTION ADVANCED TECHNOLOGIES by NORDSON CORPORATION are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Acquirer: nordson corporation